Erika B. Rosenzweig, MD Pediatrics/Pediatric Cardiology Columbia University Vagelos College of Physicians and Surgeons Biography Publications Institution JoVE Articles Erika B. Rosenzweig, MD Dr. Erika Berman Rosenzweig, Director of the Adult and Pediatric Pulmonary Hypertension Comprehensive Care Center at Columbia University Medical Center/NewYork-Presbyterian Hospital and the CTEPH Program at CUIMC, is considered an international expert in the field of pulmonary hypertension. She has tremendous clinical and research experience in the fields of adult and pediatric pulmonary hypertension. She is also Vice Chair for Clinical Research in the Department of Pediatrics. Dr. Rosenzweig is widely published and has devoted remarkable efforts toward clinical research on the study of novel treatments and genetic causes of pulmonary hypertension as well as novel approaches to mechanical support for patients with end-stage pulmonary hypertension. She has been an active member of the Pulmonary Hypertension Association (PHA) and is currently a Distinguished Advisor formerly on the Board of Trustees of the PHA, Immediate past Chair of the Scientific Leadership Council of the PHA, past Chair of the Review Committee for PHCC PH Center Accreditation Program, and past Editor-in Chief of the medical journal Advances in Pulmonary Hypertension. Dr. Rosenzweig is on the Scientific Board of the World Symposium on PH Association. Publications Correction To: Rare Variant Analysis of 4241 Pulmonary Arterial Hypertension Cases from an International Consortium Implicates FBLN2, PDGFD, and Rare De Novo Variants in PAH Genome Medicine. Jun, 2021 | Pubmed ID: 34158098 Characterisation of Pediatric Pulmonary Hypertensive Vascular Disease from the PPHNet Registry The European Respiratory Journal. Jun, 2021 | Pubmed ID: 34140292 Rare Variant Analysis of 4241 Pulmonary Arterial Hypertension Cases from an International Consortium Implicates FBLN2, PDGFD, and Rare De Novo Variants in PAH Genome Medicine. May, 2021 | Pubmed ID: 33971972 Congenital Heart Disease-Associated Pulmonary Hypertension Clinics in Chest Medicine. 03, 2021 | Pubmed ID: 33541620 Commentary: Will the Reversed Potts Shunt Replace Lung Transplantation for Children with End-stage Pulmonary Arterial Hypertension? The Journal of Thoracic and Cardiovascular Surgery. 03, 2021 | Pubmed ID: 33334602 A Novel Unidirectional-valved Shunt Approach for End-stage Pulmonary Arterial Hypertension: Early Experience in Adolescents and Adults The Journal of Thoracic and Cardiovascular Surgery. Apr, 2021 | Pubmed ID: 31839227 Impact of Coronavirus Disease 2019 (COVID-19) on Patients With Congenital Heart Disease Across the Lifespan: The Experience of an Academic Congenital Heart Disease Center in New York City Journal of the American Heart Association. 12, 2020 | Pubmed ID: 33196343 Right Ventricular Clot in Transit in COVID-19: Implications for the Pulmonary Embolism Response Team JACC. Case Reports. Jul, 2020 | Pubmed ID: 32835284 Targeted Therapy for Pulmonary Hypertension in Premature Infants Children (Basel, Switzerland). Aug, 2020 | Pubmed ID: 32824244 Cardiac Workup and Monitoring in Hospitalised Children with COVID- 19 Cardiology in the Young. Jul, 2020 | Pubmed ID: 32611457 SARS-CoV-2 Infection in Patients with Down Syndrome, Congenital Heart Disease, and Pulmonary Hypertension: Is Down Syndrome a Risk Factor? The Journal of Pediatrics. Oct, 2020 | Pubmed ID: 32610168 Could Pulmonary Arterial Hypertension Patients Be at a Lower Risk from Severe COVID-19? Pulmonary Circulation. Apr-Jun, 2020 | Pubmed ID: 32426113 A Rare Childhood Case of Behcet's Disease and Chronic Thromboembolic Pulmonary Hypertension Journal of Cardiac Surgery. Jul, 2020 | Pubmed ID: 32419255 Extracorporeal Life Support Bridge for Pulmonary Hypertension: A High-volume Single-center Experience The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation. 12, 2019 | Pubmed ID: 31582284 Response: Still Puzzling About a Clear Definition of Pulmonary Arterial Hypertension in Newborns The European Respiratory Journal. Mar, 2019 | Pubmed ID: 30923178 A Large Animal Model for Pulmonary Hypertension and Right Ventricular Failure: Left Pulmonary Artery Ligation and Progressive Main Pulmonary Artery Banding in Sheep Rei Ukita1, John W. Stokes1, W. Kelly Wu1, Jennifer Talackine1, Nancy Cardwell1, Yatrik Patel1, Clayne Benson5, Caitlin T. Demarest1, Erika B. Rosenzweig3, Keith Cook2, Emily J. Tsai4, Matthew Bacchetta1,6 1Department of Thoracic Surgery, Vanderbilt University Medical Center, 2Department of Biomedical Engineering, Carnegie Mellon University, 3Department of Pediatrics, Columbia University Medical Center, Columbia University Irving Medical Center, 4Department of Medicine, Columbia University Medical Center, Columbia University Irving Medical Center, 5Department of Anesthesiology, Vanderbilt University Medical Center, 6Department of Biomedical Engineering, Vanderbilt University JoVE 62694 Bioengineering
A Large Animal Model for Pulmonary Hypertension and Right Ventricular Failure: Left Pulmonary Artery Ligation and Progressive Main Pulmonary Artery Banding in Sheep Rei Ukita1, John W. Stokes1, W. Kelly Wu1, Jennifer Talackine1, Nancy Cardwell1, Yatrik Patel1, Clayne Benson5, Caitlin T. Demarest1, Erika B. Rosenzweig3, Keith Cook2, Emily J. Tsai4, Matthew Bacchetta1,6 1Department of Thoracic Surgery, Vanderbilt University Medical Center, 2Department of Biomedical Engineering, Carnegie Mellon University, 3Department of Pediatrics, Columbia University Medical Center, Columbia University Irving Medical Center, 4Department of Medicine, Columbia University Medical Center, Columbia University Irving Medical Center, 5Department of Anesthesiology, Vanderbilt University Medical Center, 6Department of Biomedical Engineering, Vanderbilt University JoVE 62694 Bioengineering
